Two ONAMI companies—Amorphyx and DesignMedix—place in the WAC final five

May 07 2013

Corvallis, Ore. – May 7, 2013 – Oregon Nanoscience and Microtechnologies Institute (ONAMI) is playing a front and center role in this year’s Willamette Angel Conference (WAC), held this year on May 9 at Oregon State University’s CH2M Hill Alumni Center, by having provided the start-up funding for two of the five finalists, out of an initial field of 40, in competition for a grand prize of $200,000. Another ONAMI gap company is among the “concept stage” competition candidates.

ONAMI Candidates for WAC 2013 Prize

  • Amorphyx has the distinction of having been awarded both an ONAMI Gap Grant and a second Gap grant funded jointly by ONAMI and the US Economic Development Administration’s i6 Challenge program. Amorphyx’s innovative edge in flat panel display technology offers an alternative to thin-film transistor in backplane switching technology. Amorphyx is based in Corvallis.
  • DesignMedix, based in Portland, also received its start-up funding under ONAMI’s Gap program. DesignMedix develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases.

Eugene-based QE Chemicals, is another ONAMI Gap company funded in partnership with the US EDA. QE Chemicals was selected as a finalist in the WAC’s “concept stage” category. These early stage ventures are competing for $2,500 in cash plus services that could help them turn a slick idea into the bones of a viable business.

The Willamette Angel Conference is organized by the Eugene Chamber of Commerce. The cost to attend is $99 for the general public or $50 for students, including breakfast and lunch. For registration information, see the conference website at 2013 Willamette Angel Conference.

About ONAMI (Oregon Nanoscience and Microtechnologies Institute)
ONAMI is an alliance of academic, industry and government leaders committed to technology-based economic growth in Oregon by accelerating the research and commercialization of advanced materials and device technologies. ONAMI has three major programs: (1) The ”High Tech Extension” program which connects Oregon’s academic research facilities to industry and startups on a fee-for-service basis; (2) The ONAMI Commercialization Gap Fund: helping entrepreneurs transition technology from discovery to business success through university partnerships and mentoring by ONAMI’s entrepreneurs-in-residence; and (3) Technology and talent development capacity growth by assisting collaborative teams of academia, national laboratory and industry researchers to win major federal and private funding opportunities.

Since its founding in 2004, ONAMI has leveraged $386 million in federal and private research and capital investment dollars. Thirty nine U.S. patents related to nanoscience or microtechnology have been issued to ONAMI member researchers. ONAMI’s gap fund startup companies have raised $113 million in leveraged funds.

For more information, contact:

Skip Rung, president and executive director, ONAMI
Direct (541) 713-1331
Cell (541) 231-4883
.(JavaScript must be enabled to view this email address)
www.onami.us

See also Corvallis Gazette Times story, Corvallis startup battles for big bucks (May 6, 2013).

 

Additional Links